Wall Street Zen Upgrades Billiontoone (NASDAQ:BLLN) to “Buy”

Billiontoone (NASDAQ:BLLN) was upgraded by investment analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a report released on Saturday.

A number of other equities analysts have also recently commented on the company. Stifel Nicolaus started coverage on Billiontoone in a report on Monday, December 1st. They issued a “buy” rating and a $145.00 target price on the stock. Zacks Research upgraded Billiontoone to a “hold” rating in a research report on Tuesday, December 2nd. Jefferies Financial Group assumed coverage on Billiontoone in a research note on Monday, December 1st. They issued a “hold” rating and a $117.00 price objective on the stock. Wells Fargo & Company lowered their price objective on Billiontoone from $110.00 to $90.00 and set an “equal weight” rating on the stock in a research report on Thursday. Finally, JPMorgan Chase & Co. reduced their target price on shares of Billiontoone from $150.00 to $145.00 and set an “overweight” rating for the company in a report on Wednesday, December 10th. Six equities research analysts have rated the stock with a Buy rating, three have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, Billiontoone currently has a consensus rating of “Moderate Buy” and an average price target of $129.57.

Billiontoone Price Performance

Shares of NASDAQ BLLN opened at $73.51 on Friday. Billiontoone has a 12-month low of $66.00 and a 12-month high of $138.70. The company has a market capitalization of $3.36 billion and a price-to-earnings ratio of 735.10. The firm’s 50 day simple moving average is $85.55.

Billiontoone (NASDAQ:BLLN) last released its quarterly earnings results on Wednesday, March 4th. The company reported $0.11 earnings per share for the quarter, topping the consensus estimate of $0.04 by $0.07. The business had revenue of $96.05 million during the quarter, compared to the consensus estimate of $85.85 million. The company’s revenue was up 113.0% compared to the same quarter last year.

Hedge Funds Weigh In On Billiontoone

Several hedge funds have recently modified their holdings of BLLN. Caitong International Asset Management Co. Ltd bought a new position in shares of Billiontoone during the fourth quarter worth $230,000. T. Rowe Price Investment Management Inc. bought a new stake in Billiontoone in the 4th quarter valued at $8,277,000. Invesco Ltd. purchased a new stake in Billiontoone in the 4th quarter worth $15,535,000. XTX Topco Ltd bought a new position in shares of Billiontoone during the 4th quarter valued at about $1,692,000. Finally, Quadrature Capital Ltd purchased a new position in shares of Billiontoone during the fourth quarter valued at about $614,000.

Billiontoone News Roundup

Here are the key news stories impacting Billiontoone this week:

• Positive Sentiment: Q4 earnings beat and rapid revenue growth — BillionToOne reported $0.11 EPS vs. $0.04 consensus and revenue of $96.05M (vs. $85.85M est.), with revenue up ~113% year-over-year; results and commentary point to accelerating demand. View Press Release
• Positive Sentiment: Raised FY‑2026 revenue guidance — company lifted 2026 revenue guidance to $430M–$445M vs. consensus near $356M, implying materially stronger top‑line growth than analysts expected. Press Release
• Positive Sentiment: Earnings call & investor materials highlight strategy and growth drivers — management commentary and the slide deck underscored durable revenue expansion and product/market traction that support the raised guidance. Earnings Highlights
• Positive Sentiment: Analyst support: Guggenheim reaffirmed a “buy” with a $120 PT — another buy-side vote that can buoy sentiment despite mixed firm-level price target moves. Benzinga
• Positive Sentiment: Positive coverage piece framing BLLN as an attractive investment — broader bullish narratives and coverage can amplify buying interest following the beat and guidance lift. Article
• Neutral Sentiment: Analyst deep‑dive and metric comparisons — outlets (e.g., Zacks) are parsing metrics vs. estimates and prior periods; useful for modeling but not new catalyst. Zacks
• Neutral Sentiment: Q4 snapshot pieces summarize results for retail/institutional readers — helpful context but unlikely to move price independently. LMOnline
• Neutral Sentiment: Short‑interest data appears anomalous/unchanged (reports show zeros/NaN); no clear short squeeze signal from these feeds. (Data quality issue; monitor official FINRA reports.)
• Negative Sentiment: Wells Fargo cut its price target to $90 and set an “equal weight” rating — a downgrade in conviction from that shop could cap near‑term upside and weigh on sentiment for more conservative investors. Benzinga
• Negative Sentiment: BTIG trimmed its target from $160 to $140 (still a “buy”) — target cuts reduce the extent of analyst-driven upside, even if the rating remains positive. Street Insider

About Billiontoone

BillionToOne (NASDAQ: BLLN) is a molecular diagnostics company that develops and commercializes high-precision genetic testing solutions based on single-molecule counting technology. The company’s platform is designed to detect and quantify rare genetic variants and chromosomal abnormalities from cell-free DNA, with a primary focus on applications in prenatal screening and other clinical genetic tests where sensitivity and specificity at very low allele fractions are critical.

BillionToOne’s offerings center on assay development and clinical testing workflows that enable non-invasive prenatal testing (NIPT) and targeted molecular diagnostics.